Therapeutic Efficacy in Women With Stress Urinary Incontinence

Conditions: Women With Stress Urinary Incontinence

Sex: Female

Ages: 25 Years – N/A

Phase: PHASE3

Enrollment: 90

Sponsor: Far Eastern Memorial Hospital

Location: Taiwan

Summary

We will get the impact of duloxetine versus imipramine on therapeutic efficacy in women with SUI.

Eligibility Criteria

Inclusion Criteria:Female patients over 25 years old with stress urinary incontinence.Patients who are currently not considered for surgical treatment.Patients who have undergone regular Kegel exercises but have poor results.Exclusion Criteria:The result of urodynamic examination, if the main cause of urinary incontinence is detrusor overactivity.Those who are taking or plan to take monoamine oxidase inhibitor (MAOI) inhibitors.Patients with acute myocardial infarction.Those who are allergic to duloxetine, imipramine and dibenzazepine tricyclic antidepressants.Patients with uncontrolled narrow-angle glaucoma.Pregnant women.Those who are contraindicated to duloxetine or imipramine.Patients with suicidal ideation and behavior.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05677295). StuddyBuddy aggregates publicly available trial information.